Journal Home
Search for

Volume 135, Issue 1, Pages 17-21 (July 2006)


View previous. 8 of 43 View next.

Sensory neuropathic cough: A common and treatable cause of chronic cough

Robert W. Bastian, MDaCorresponding Author Informationemail address, Abhay M. Vaidya, MDb, Kathelijne G. Delsupehe, MDc

Objective

To describe our experience with chronic sensory neuropathic cough and its response to amitriptyline in a first group of patients.

Study design and setting

A prospective cohort of patients is described in detail. Each was referred to an academic laryngological practice after extensive prior negative workup for cough and failure to respond to various treatments. Each of these patients was treated with amitriptyline and asked to report the effect on the cough at fixed intervals by means of telephone interviews.

Results

A first cohort of 12 consecutive patients with a chronic, nonproductive cough that lasted between 2 months and 20 years, with no (formerly) discernible cause is described. Purely clinical criteria of inclusion and exclusion are proposed. All patients had at least 40% reduction of self-reported symptoms, with most describing between 75% to 100% short-term relief.

Conclusion

Sensory neuropathic cough can be diagnosed clinically in patients with chronic idiopathic cough. A trial of amitriptyline 10 mg or of other antineuralgia type medications may be helpful. Longer term and controlled trials are warranted to validate this entity and prove efficacy of neurologic medication in chronic sensory neuropathic cough.

EBM rating: C-4

a Bastian Voice Institute, Downers Grove, Illinois

b West Coast Ear, Nose, and Throat, Thousand Oaks, California

c Heilig Hart Hospital, Roeselare, Belgium

Corresponding Author InformationReprint requests: Robert W. Bastian, MD, Bastian Voice Institute, 3010 Highland Parkway, Suite 550, Downers Grove, IL 60515.

 Work performed at Loyola University Medical Center.

PII: S0194-5998(06)00151-3

doi:10.1016/j.otohns.2006.02.003


View previous. 8 of 43 View next.